Concepedia

Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells

Shiyong Li, Rong Sun, Hongxia Wang, Song Shen, Yang Liu, Xiao‐Jiao Du, Yanhua Zhu

Journal of Controlled Release · 2014 · 128 citations · 32 references

DOI

Concepts

References

32

ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe‐Jauffret et al. · Cell stem cell · 2007 · 4K citations · Full text

, , +14

A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

Joyce E. Ohm, Kelly M. McGarvey, Xiaobing Yu et al. · Nature Genetics · 2007 · 1.1K citations · Full text

, , +17

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

, , +17

Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition

Marı́a S. Soengas, Rodolfo Alarcón, Hiroki Yoshida et al. · Science · 1999 · 663 citations

, , +17

Self-porating polymersomes of PEG–PLA and PEG–PCL: hydrolysis-triggered controlled release vesicles

Fariyal Ahmed, Dennis E. Discher · Journal of Controlled Release · 2004 · 658 citations

, , +17